Madison KnappMadison Knapp has a Bachelor of Science degree from the University of Missouri. With years of business development and scientific communications experience within the industry, Madison joins Alturas with an understanding of organizations specializing in regulated bioanalysis, in vitro drug-drug interaction studies, GLP toxicology studies, and full service clinical trial management. As part of the Business Development team at Alturas, Madison supports clients on the west coast, nurturing new and existing client relationships and representing Alturas at conferences and trade shows.
Kayla Robertson
Dr. Andrew TaylorDr. Andrew G. Taylor earned his Ph.D. from the University of California San Diego and has built a career at the intersection of drug metabolism, regulatory compliance, and business development. Currently, he serves as the Territory Director of Business Development for the East Coast with Alturas Analytics, where he partners with pharmaceutical and biotech companies to advance bioanalytical solutions. His background in nonclinical drug interaction studies and scientific support provides a strong foundation for understanding client needs and fostering collaborative success.
Renee Falzone
John IngramJohn Ingram earned a BS in General Chemistry and a Masters in Physical Chemistry from the University of Idaho and an MBA from Webster University. He has worked in the business development and science and technology fields for over 20 years in both the government and private sectors. As part of the Business Development team at Alturas, John fills an integral role as an interface for understanding the bioanalytical needs of prospective clients and transfer of information to the Alturas scientific staff for assessment. He is also responsible for analyzing current bioanalytical approaches and industry trends to identify potential opportunities for growth.
Maggie McMullenMaggie McMullen is the Chief Business Development Officer at Alturas Analytics, Inc. She graduated from the University of Wisconsin – Madison in 1996 and has earned a Certificate of Leadership from the American Management Association in 2012. With over 20 years in the CRO industry, her primary objective is to strengthen Alturas’ business planning strategies, focus on building internal and external relationships and to foster company growth as a leader in the LC-MS/MS and GC-MS/MS bioanalytical field. Key to this position is identifying opportunities for expansion, customers, markets, and new industry developments and standards.
